Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/14338
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Association between CYP2C19 genotype and proguanil oxidative polymorphism.
Author: Coller, J.
Somogyi, A.
Bochner, F.
Citation: British Journal of Clinical Pharmacology, 1997; 43(6):659-660
Publisher: BLACKWELL SCIENCE LTD
Issue Date: 1997
ISSN: 0306-5251
1365-2125
Abstract: <h4>Aims</h4>To examine the relationship between proguanil metabolism and the number of mutations in CYP2C19 by comparing the CYP2C19 genotype and proguanil phenotype of 10 subjects.<h4>Methods</h4>Partial clearance and urinary metabolic ratio data were obtained from a previous study of 10 subjects [5]. Analysis of CYP2C19 genotypes was performed using PCR amplification followed by restriction endonuclease digestion of genomic DNA from a blood sample.<h4>Results</h4>The intrinsic partial clearance of PG to CG ranged from 0.41-10.11 h-1, and was related to the number of functional CYP2C19 alleles present. Genotypic PMs had metabolic ratios > 13, while genotypic heterozygote EMs had metabolic ratios < 9.<h4>Conclusions</h4>Proguanil may be a suitable phenotyping probe for the CYP2C19 genetic polymorphism, however the exact antimode of the urinary metabolic ratio chosen to separate poor and extensive metabolisers needs further investigation.
Keywords: Humans
Cytochrome P-450 Enzyme System
Aryl Hydrocarbon Hydroxylases
DNA Restriction Enzymes
Mixed Function Oxygenases
DNA
Antimetabolites
Administration, Oral
Polymerase Chain Reaction
Gene Expression Regulation, Enzymologic
Genotype
Heterozygote
Phenotype
Polymorphism, Genetic
Alleles
Proguanil
Cytochrome P-450 CYP2C19
Asian People
White People
DOI: 10.1046/j.1365-2125.1997.00596.x
Published version: http://dx.doi.org/10.1046/j.1365-2125.1997.00596.x
Appears in Collections:Aurora harvest 2
Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.